Results 131 to 140 of about 76,081,297 (156)

Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy. [PDF]

open access: yesClin Cancer Res, 2021
Sun J, Lu Q, Sanmamed MF, Wang J.
europepmc   +1 more source

490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Omid Hamid   +14 more
doaj   +1 more source

Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. [PDF]

open access: yesProc Natl Acad Sci U S A
Wang Y   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

CD24-Siglec Axis Is an Innate Immune Checkpoint Against Metaflammation and Metabolic Disorder

Cell Metabolism, 2022
Guo-Yun Chen   +2 more
exaly  

Siglec and Anti-Siglec Therapies

Current Opinion in Chemical Biology, 2021
Paul R. Crocker   +2 more
exaly  

Home - About - Disclaimer - Privacy